Researchers across multiple areas of neuroscience are continuing to push beyond symptom management and explore therapies that may help protect, restore, and preserve brain function after injury and disease. A new study on elovanoids found that these lipid-derived molecules helped reduce inflammation, limit neuronal damage, and preserve synaptic integrity following traumatic brain injury, pointing to the growing importance of cellular protection and mitochondrial health in recovery. Another study showed that leriglitazone, a brain-penetrant PPARγ activator, improved motor function and reduced neurodegeneration and neuroinflammation in a mouse model of COASY dysfunction, offering encouraging insight for rare neurodegenerative disorders like CoPAN and related NBIA conditions.

At the same time, researchers studying vascular dementia after stroke are exploring how gene therapy could support long-term cognitive recovery by targeting neurovascular repair, white matter injury, inflammation, and cell survival pathways. Together, these studies reflect a larger shift in neuroscience toward therapies designed not only to slow damage, but also to strengthen the brain’s ability to recover and maintain function at the cellular and vascular levels. While the diseases and injuries differ, the shared focus on neuroprotection, inflammation control, and tissue repair highlights how interconnected many neurological conditions may be, and why advances in one area could eventually influence treatment strategies across many others.